Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands
申请人:Cole Cecil Derek
公开号:US20050020596A1
公开(公告)日:2005-01-27
The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
本发明提供了I式化合物的复合物,并将其用于治疗与或受5-HT6受体有关的中枢神经系统疾病的治疗中。
Savelli; Boido; Pirisino, Farmaco, Edizione Pratica, 1987, vol. 42, # 11, p. 833 - 844
作者:Savelli、Boido、Pirisino、Piu、Satta、Manca
DOI:——
日期:——
SAVELLI, F.;BOIDO, A.;MULE, A., BOLL. CHIM. FARM. , 128,(1989) N, C. 132-135
作者:SAVELLI, F.、BOIDO, A.、MULE, A.
DOI:——
日期:——
MULE, A.;PIRISINO, G.;MANCA, P.;SATTA, M.;PEANA, A.;SAVELLI, F., FARMACO: ED. SCI., 43,(1988) N 7-8, C. 613-618
作者:MULE, A.、PIRISINO, G.、MANCA, P.、SATTA, M.、PEANA, A.、SAVELLI, F.
DOI:——
日期:——
SULFONYLDIHYDROIMID- AZOPYRIDINONE COMPOUNDS AS 5-HYDROXYTRYPTAMINE-6 LIGANDS